These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29240593)

  • 1. Insights into the Pathophysiology of Hypertrophic Scars and Keloids: How Do They Differ?
    Adv Skin Wound Care; 2018 Jan; 31(1):E1. PubMed ID: 29240593
    [No Abstract]   [Full Text] [Related]  

  • 2. Epithelial-mesenchymal transition in the formation of hypertrophic scars and keloids.
    Yuan FL; Sun ZL; Feng Y; Liu SY; Du Y; Yu S; Yang ML; Lv GZ
    J Cell Physiol; 2019 Dec; 234(12):21662-21669. PubMed ID: 31106425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scars and keloids.
    Murray JC
    Dermatol Clin; 1993 Oct; 11(4):697-708. PubMed ID: 8222353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperplastic scars and keloids. Part I: basics and prevention].
    Baisch A; Riedel F
    HNO; 2006 Nov; 54(11):893-904; quiz 905. PubMed ID: 17041777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders.
    Ogawa R; Akaishi S
    Med Hypotheses; 2016 Nov; 96():51-60. PubMed ID: 27959277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrillin-1 and elastin are differentially expressed in hypertrophic scars and keloids.
    Amadeu TP; Braune AS; Porto LC; Desmoulière A; Costa AM
    Wound Repair Regen; 2004; 12(2):169-74. PubMed ID: 15086768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the Pathophysiology of Hypertrophic Scars and Keloids: How Do They Differ?
    Ghazawi FM; Zargham R; Gilardino MS; Sasseville D; Jafarian F
    Adv Skin Wound Care; 2018 Jan; 31(1):582-595. PubMed ID: 29240586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
    Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
    Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of keratins during abnormal wound healing in human skin.
    Prathiba V; Rao KS; Gupta PD
    Cytobios; 2001; 104(405):43-51. PubMed ID: 11219730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertrophic or keloid scars?
    McGrouther DA
    Eye (Lond); 1994; 8 ( Pt 2)():200-3. PubMed ID: 7958022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascularization pattern in hypertrophic scars and keloids: a stereological analysis.
    Amadeu T; Braune A; Mandarim-de-Lacerda C; Porto LC; Desmoulière A; Costa A
    Pathol Res Pract; 2003; 199(7):469-73. PubMed ID: 14521263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of TGF-β1 in keloids and hypertrophic scars.
    Abdou AG; Maraee AH; Al-Bara AM; Diab WM
    Am J Dermatopathol; 2011 Feb; 33(1):84-91. PubMed ID: 20559120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous scars: Part I.
    Sahl WJ; Clever H
    Int J Dermatol; 1994 Oct; 33(10):681-91. PubMed ID: 8002135
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunohistochemical Evaluation of Leptin Expression in Wound Healing: A Clue to Exuberant Scar Formation.
    Seleit I; Bakry OA; Samaka RM; Tawfik AS
    Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):296-306. PubMed ID: 26258753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased epidermal thickness and abnormal epidermal differentiation in keloid scars.
    Limandjaja GC; van den Broek LJ; Waaijman T; van Veen HA; Everts V; Monstrey S; Scheper RJ; Niessen FB; Gibbs S
    Br J Dermatol; 2017 Jan; 176(1):116-126. PubMed ID: 27377288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keloids and hypertrophic scars: are they two different sides of the same coin?
    Köse O; Waseem A
    Dermatol Surg; 2008 Mar; 34(3):336-46. PubMed ID: 18177398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hypertrophic scars and keloids with a radiofrequency device: a study of collagen effects.
    Meshkinpour A; Ghasri P; Pope K; Lyubovitsky JG; Risteli J; Krasieva TB; Kelly KM
    Lasers Surg Med; 2005 Dec; 37(5):343-9. PubMed ID: 16365887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in collagen architecture between keloid, hypertrophic scar, normotrophic scar, and normal skin: An objective histopathological analysis.
    Verhaegen PD; van Zuijlen PP; Pennings NM; van Marle J; Niessen FB; van der Horst CM; Middelkoop E
    Wound Repair Regen; 2009; 17(5):649-56. PubMed ID: 19769718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inadequate blood supply persists in keloids.
    Ueda K; Yasuda Y; Furuya E; Oba S
    Scand J Plast Reconstr Surg Hand Surg; 2004; 38(5):267-71. PubMed ID: 15513596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analyses of the stratum corneum in scars. Sequential studies after injury and comparison among keloids, hypertrophic scars, and atrophic scars.
    Suetake T; Sasai S; Zhen YX; Ohi T; Tagami H
    Arch Dermatol; 1996 Dec; 132(12):1453-8. PubMed ID: 8961874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.